News & Insights

Mask Group (4)

America’s National Security Vulnerability: Generic Drug Manufacturing and Biotechnology Innovation

BENS Assessment that outlines policy recommendations to strengthen U.S. pharmaceutical supply chains

Scorecard

The National Security Private Investment Scorecard

A Practitioner Recommendation for Mobilizing Private Capital by Wayne Sanders

InsurancePools

Defense Contractor Stability Pool: Converting Termination Risk into Insurable Protection 

A Practitioner Recommendation for Mobilizing Private Capital by Andrew Hersh

DIBAccelerator

The DIB Transition Accelerator: De-Risking M&A to Lower the Cost of Capital for Small Defense Businesses 

A Practitioner Recommendation for Mobilizing Private Capital by Michael Dworkis

OpeningDefenseProduction

Operation Arsenal Speed: Open Defense Production to Commercial Manufacturers

A Practitioner Recommendation for Mobilizing Private Capital by Stan Crow

Argentina Trip Report Cover

Countering Influence, Securing Opportunity: A Private Sector View from Argentina

Analysis and 10 recommendations following a BENS delegation visit to Buenos Aires, where they examine how a stronger U.S.-Argentina partnership can counter growing Chinese influence

Digital artwork created using OpenAI’s ChatGPT.

Arsenal of Democracy 2.0: Mobilizing Modern Capital for America’s Defense

By General Timothy M. Ray, USAF (Ret.) & Al Puchala

Hundred Argentine pesos

How to Fix Argentina’s Currency Crisis

By BENS President & CEO Gen. Tim Ray (Ret.) and BENS Vice Chair Ramon Marks, published in The National Interest. All rights reserved. The United States must do more than…

PharmaBlackout

Pharmaceutical Blackout: The Hidden Threat to U.S. Security

By BENS Member Stuart Glickman and BENS President & CEO Gen. Tim Ray (Ret.), published in RealClearDefense.

Capital Markets NI

How Capital Markets Can Revive the Defense Industrial Base

By BENS Board Director Frank Finelli and Member David Bonfili, via The National Interest